Bi/ond Solutions

BI/OND Solutions B.V. is a Dutch medtech company that engineers, develops, and supplies organ-on-a-chip technology to advance biological research. Founded in 2017 by Dr. Cinzia Silvestri (CEO), Dr. Nikolas Gaio (CTO), and Dr. William Solano (COO), the company emerged from the Organ-on-Chip research field at the Delft University of Technology. The founders combined their expertise in microelectronics, bioengineering, and tissue engineering to create a more effective platform for in-vitro studies.

The company's core product is the BI/OND Platform, a system that uses microfluidic chips to create dynamic, three-dimensional micro-environments that mimic human organs and tissues. This technology provides researchers with a more physiologically relevant alternative to traditional 2D cell cultures and animal models for applications like drug discovery and personalized medicine. The platform is designed to be user-friendly, allowing biologists without a background in engineering to conduct complex experiments. It consists of in-vitro chips, an Instrument Controller for precise temperature and fluid flow regulation, and software for experiment design and data monitoring.

BI/OND Solutions operates on a business-to-business (B2B) model, selling its hardware and consumables directly to pharmaceutical companies, academic research institutions, and contract research organizations (CROs). By enabling the creation of patient-specific models using patient-derived cells, the technology aims to accelerate the development of new therapies and make personalized medicine a reality.

Keywords: organ-on-a-chip, microfluidics, in-vitro models, drug discovery, personalized medicine, cell culture, tissue engineering, life sciences, medtech, bioengineering